Why We Created the Coney Medical Technologies Fund

The Coney Medical Technologies Fund was created to support the growth of a medical technology that addresses one of the largest unmet needs in healthcare: safe, effective treatment for chronic pain. Millions of patients suffer from temporomandibular joint dysfunction (TMJ) and chronic anterior knee pain, yet treatment options are often limited to physical therapy, long-term medication, or invasive procedures that may not provide lasting relief.

When the opportunity emerged to invest in a proprietary, FDA-cleared device designed to treat both conditions with a non-invasive, non-opioid approach, we recognized the potential to support a solution that could benefit patients, providers, and the healthcare system as a whole.

The Fund was established to provide the capital needed to accelerate commercialization, expand clinical adoption, and scale manufacturing and distribution. With regulatory clearance already in place and a large global market, the focus is on execution- bringing a validated technology to more practices and more patients.

We created the Coney Medical Fund to back innovation that has the potential to improve outcomes, reduce reliance on medication, and help redefine how chronic pain is treated.

Sign up to get notified of fund launches and IPO’s at www.coneymedical.com

This press release is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities. Any offering of interests in the Investment Fund will be made only pursuant to formal offering documents, which include important information about the investment objectives, risks, fees, and expenses. Prospective investors should carefully review such documents before making any investment decision.

IMPORTANT LEGAL DISCLOSURE: REGULATION D, RULE 506(c) OFFERING

This offering is a private placement of securities pursuant to Rule 506(c) of Regulation D under the Securities Act of 1933, as amended. The following conditions strictly apply:

1. Accredited Investors Only: All securities offered by the Fund are available only to Accredited Investors as defined by Rule 501 of Regulation D.
2. Mandatory Verification: The Issuer is required to, and will, take reasonable steps to verify the accredited status of every purchaser. Your self-certification is insufficient. You will be required to provide evidence of your accredited status (e.g., income verification or professional certifications) before your investment can be finalized.
3. General Solicitation: Due to the use of Rule 506(c), the Fund engages in general solicitation and advertising, including this website.
4. Risk Disclosure: Investment in the Fund involves a high degree of risk, is speculative, and is suitable only for accredited investors who can bear the entire risk of the loss of their investment. The securities have not been registered under the Securities Act of 1933, as amended, or any state securities laws.

Review of the Private Placement Memorandum (PPM) is required prior to any investment decision.

1. Statutory Safe Harbor for Forward-Looking Statements

This legend protects the Fund’s management from liability under federal securities laws for projections and expectations, provided the statements were made with a reasonable basis and identified by specific cautionary factors.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This website, along with all associated materials, including the Private Placement Memorandum (PPM) and all oral statements made by the management of the Fund, contain certain “forward-looking statements.” All statements other than those of historical facts are forward-looking statements.

These statements generally relate to the Fund’s planned activities, projected performance, financial expectations, and investment goals, and can often be identified by words such as “will,” “aim,” “target,” “anticipate,” “project,” “expect,” “potential,” “goal,” “estimate,” “may,” “should,” “intends,” or the negative of these terms or similar expressions.

Forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that may cause the actual results of the Fund, or the performance of its investments, to differ materially from those expressed or implied by such statements.

Such risks and uncertainties include, but are not limited to:

• Risks inherent in real estate investment and development (e.g., construction delays, cost overruns, changes in zoning/permitting).
• Economic and market risks .
• The Fund’s ability to successfully raise the target capital
• Reliance on the expertise and continued involvement of key personnel, including the Fund’s sponsor and management team.
• General business, financial, and economic conditions.

You are cautioned not to place undue reliance on these forward-looking statements. The Fund is under no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required by law. All prospective investors must consult the “Risk Factors” section of the Private Placement Memorandum for a more complete discussion of the risks and uncertainties associated with an investment in the Fund.

2. Mandatory Rule 506(c) Disclosure Legend

This is a non-negotiable compliance legend that must appear prominently on the website and all offering materials to maintain the integrity of the private placement exemption.

MANDATORY LEGAL DISCLOSURE (REGULATION D, RULE 506(c))

THE SECURITIES OFFERED HEREIN HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR THE SECURITIES LAWS OF ANY STATE, AND ARE BEING OFFERED AND SOLD IN RELIANCE ON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT.

THE FUND IS RELYING ON RULE 506(C) OF REGULATION D. ACCORDINGLY, ALL PURCHASERS MUST BE ACCREDITED INVESTORS (AS DEFINED IN RULE 501 OF REGULATION D), AND THE ISSUER IS REQUIRED TO TAKE REASONABLE STEPS TO VERIFY THAT PURCHASERS ARE ACCREDITED INVESTORS.

THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM.

NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR PASSED UPON THE ADEQUACY OR ACCURACY OF THIS OFFERING MEMORANDUM. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

INVESTMENT IN THE FUND INVOLVES A HIGH DEGREE OF RISK AND IS SUITABLE ONLY FOR ACCREDITED INVESTORS WHO CAN BEAR THE ECONOMIC RISK OF THE COMPLETE LOSS OF THEIR INVESTMENT.

Required Regulation A Disclaimer for Marketing Materials

Regulation A Testing the Waters Disclosure

No money or other consideration is being solicited, and if sent in response, it will not be accepted. No offer to buy securities can be accepted, and no part of the purchase price can be received, until an offering statement filed with the Securities and Exchange Commission has been qualified. Any indication of interest in response to this communication involves no obligation or commitment of any kind.

A potential investor’s indication of interest is non-binding. Any offering of securities will be made only through an Offering Circular that forms a part of the qualified Offering Statement. Before investing, you should carefully review the Offering Circular, including the Risk Factors section, and the other documents the issuer has filed with the Securities and Exchange Commission.

Forward-Looking Statements

This communication may contain forward-looking statements that are based on current expectations and assumptions. Actual results may differ materially. Neither the SEC nor any state securities regulator has approved or disapproved of the securities or determined whether this communication is truthful or complete.

State (Blue Sky) Notice

The securities referenced in a Regulation A offering may be offered and sold only in states where they are permitted under applicable Blue Sky laws. Qualification by the SEC does not imply approval by any state securities regulator.